Concurrent Use Lymphoseek & Indocyanine Green in Sentinel Lymph Node Detection in Endometrial Cancer

Inclusion Criteria:

* The patient has histological diagnosis of cancer of the endometrium of any histology or grade.
* The patient should have received no prior treatment for her endometrial cancer.
* The patient has clinically uterine confined disease.
* The patient is a candidate for minimal invasive surgery, with sentinel lymph node assessment with IC-GREEN planned as part of standard of care.
* The patient has an Eastern Cooperative Group (ECOG) performance status of 0-2.
* If age less than or equal to 55 years, the patient has a negative pregnancy test within 72 hours before administration of Lymphoseek, has been surgically sterilized, or has been postmenopausal for at least 1 year.
* The patient has provided written informed consent.
* The patient is at least 18 years of age at the time of consent

Exclusion Criteria:

* The patient has clinical or radiological evidence of metastatic disease.
* The patient has a history of a prior loop electrosurgical excision procedure (LEEP) or cone procedure performed on her cervix.
* The patient has participated in another investigational drug study within 30 days of scheduled surgery.
* The patient has an iodine allergy.
* The patient is pregnant or lactating.